Sign in

NCT05232240Recruiting

Blood Pressure Variability in Non-hypertensive Patients With Ischemic Cerebrovascular Disease

Source: ClinicalTrials.gov · Last updated 14 Mar 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study is a single-center prospective cohort of patients with ischemic cerebrovascular disease (ICVD) who have not met the diagnostic criteria for hypertension. Ambulatory 24-hour blood pressure monitoring (ABPM) will be performed at baseline and one year after the enrollment. The primary purpose of the study is to delineate the relationship of blood pressure variability (BPV) with the risk of composite vascular events in non-hypertensive patients with ICVD. The factors related to BPV, as well as the potential modulators of the associations between BPV and vascular risk, will be further explored among these patients.

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
30 Jan 2022
Start date
14 Feb 2022
Primary completion date
28 Feb 2027
Lead sponsor
Xuanwu Hospital, Beijing
Diseases
Stroke
NCT number
NCT05232240

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 14 Feb 2022 to the primary completion date, 28 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • A definite diagnosis of hypertension.
  • Under anti-hypertension treatment.
  • Worsening neurological conditions.
  • With a National Institute of Health Stroke Scale score more than 5 points.
  • Intracranial hemorrhage.
  • Autonomic failure.
  • With malignant tumors or poor organ functions or hematologic diseases, whose estimated life expectancy is less than 3 years.
  • Mental disease.

Other

  • With contraindications to ambulatory 24-hour blood pressure monitoring or fail to finish the examination at baseline.
  • Pregnant.

Who the study is looking for

  • Diagnosed as ischemic stroke or transient ischemic attack (TIA), with confirmation of computed tomography or magnetic resonance imaging.
  • Less than 90 days after onset of ischemic stroke or TIA symptoms.
  • The blood pressure measured 5\~90 days after the ICVD onset without any anti-hypertension treatment is less than 140/90 mmHg (an average of ≥2 readings obtained on ≥ 2 occasions after emptying bladder, relaxing for more than 5 min, and avoiding caffeine, exercise, or smoking for at least 30 min before measurement).
  • Consent to participate in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Xuanwu Hospital, Capital Medical University
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.